Mutations in KIAA1217, POLD1, PIEZO1, NBEAL2, DDX17, and PARP14 were significantly more prevalent in patients with colon cancer and PRShigh than in those with PRSlow (Figure 5c). This evidence concerns the gene PARP14 and malignant colon neoplasm.